Palmitoylethanolamide (PEA)

DIETARY_SUPPLEMENT4 trials

Sponsors

The University of Texas Health Science Center, Houston, RDC Clinical Pty Ltd, Benha University

Conditions

AnxietyBipolar DepressionHealthyPain After Extracorporeal Shock Wave LithotripsyPalmitoylethanolamideSafetySleep Disorder (Disorder)Stress

Phase 2

A Trial of the Fatty Acid Amide Hydrolase Inhibitor Palmitoylethanolamide in Bipolar Depression

CompletedNCT06229977

The University of Texas Health Science Center, HoustonBipolar Depression

Start: 2023-05-17End: 2025-07-17Updated: 2025-10-02

Long-Term PEA Safety Study

RecruitingNCT06717867

RDC Clinical Pty LtdHealthy, Safety

Start: 2025-01-22End: 2027-06-30Target: 200Updated: 2025-12-18

Sleep and Stress Study

Not yet recruitingNCT07315516

RDC Clinical Pty LtdAnxiety, Sleep Disorder (Disorder), Stress

Start: 2026-02-28End: 2027-02-28Target: 240Updated: 2026-01-02

Unknown Phase

Palmitoylethanolamide vs Ibuprofen for Pain After ESWL

Not yet recruitingNCT07316660

Benha UniversityPain After Extracorporeal Shock Wave Lithotripsy, Palmitoylethanolamide

Start: 2026-01-01End: 2026-07-01Target: 120Updated: 2026-01-05